Dr. Sameer Khatri is a highly accomplished Medical Oncologist with over 25 years of medical experience, including more than 15 years dedicated to oncology practice. A graduate of Maulana Azad Medical College and trained at Rajiv Gandhi Cancer Institute, he specializes in precision oncology, immunotherapy, and targeted cancer treatments. Dr. Khatri is known for his compassionate, patient-centered approach and his expertise in treating a wide range of cancers including breast, lung, and gastrointestinal malignancies. He has also led oncology departments in reputed institutions and contributed to collaborative cancer care and research initiatives in India.
Educational Qualifications:
- DNB (Medical Oncology) – Rajiv Gandhi Cancer Institute & Research Centre, Delhi (2007)
- MD (Internal Medicine) – Maulana Azad Medical College, Delhi (1999)
- MBBS – Maulana Azad Medical College, Delhi (1994)
Professional Experience:
- Dr. Sameer Khatri is currently working at Max Healthcare
- Director & Head - Medical Oncology, Shanti Mukand Hospital Cancer Centre, Delhi (2018-2023)
- Senior Consultant - Medical Oncology, Max Super Speciality Hospital, Vaishali (2016-2018)
- Senior Consultant – Medical Oncology, HCG–SMH-Curie Cancer Centre, Delhi (2009-2016)
- Consultant – Medical Oncology, (2008-2009), BL Kapur Memorial Hospital, Delhi.
- Conusultant – Medical Oncology, HCG–SMH-Curie Cancer Centre, Delhi (2007-2008)
Professional Memberships:
- Membership of European Society of Medical Oncology ESMO
- Indian Society of Medical & Paediatric Oncology
- Indian Co-operative Oncology Network ICON
Research Papers & Publications:
- Principle Investigator in Phase IV Clinical Trail – A Retrospective Evaluation of Efficacy & Safety of Chemotherapeutic Formulations of Fersenius kabi Oncology (Gemcixtabine, Docetaxel, Irinotecan, Oxaliplation and Paclitaxel versrus Historical Data in CRC, SCCHN, NSCLC, Pancreatic Carcinoma, Gastric Adenocarcinoma).
- Principle Investigator in Phase II Trail of Bavituximab plus docetaxel in patients with previously treated locally advanced or metastatic non – squqmous non-small lung cancer.